Adcetris (brentuximab vedotin)
- « Back to Catalog
-
Adcetris (brentuximab vedotin) is an antibody-drug conjugate used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
-
Previous Post
Next Post
Adcetris (brentuximab vedotin) is an antibody-drug conjugate used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.